Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2012-10-05 to 2012-11-29
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2012
Report date:
2012

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.3 (Acute Toxicity (Dermal))
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
fixed dose procedure
Limit test:
yes

Test material

Constituent 1
Test material form:
other: liquid
Details on test material:
Sponsor's identification: 400112
Date received: 24 September 2012
Container: brown glass flask (n=1)
Quantity: 93.15 g (container + contents)
Batch No: 0001273679
Production date: May 2011
Expiry date: May 2013
Purity: 100% (not purified but used as synthesized)
Composition: UVCB substance
Colour: yellow-brown
Storage: room temperature

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female

Administration / exposure

Type of coverage:
occlusive
Vehicle:
unchanged (no vehicle)
Duration of exposure:
24 h
Doses:
effective dose: 2000 mg/kg bw
corresponding to a volume of 2.05 mL/kg bw
No. of animals per sex per dose:
5
Control animals:
no

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
no
Clinical signs:
other: no
Gross pathology:
The macroscopic examination of the animals at the end of the study did not reveal treatment-related changes.
Other findings:
Cutaneous reactions (erythema and scab) were noted in all animals from 24 or 48 h post-dose and were totally reversible in females on day 10 and in males on day 14.

Applicant's summary and conclusion

Interpretation of results:
other: not classified according to EU regulation
Conclusions:
The dermal LD50 of the test item 400112 was higher than 2000 mg/kg body weight in the rat.
In accordance with the Regulation EC No. 1272/2008, the test item does not have to be classified.
Executive summary:

The test item 400112 was applied onto the intact skin of 10 Sprague-Dawley rats (5 males and 5 females) at a single dose of 2000 mg/kg body weight. The experimental protocol was established on the basis of the official method as defined in the OECD guideline No. 402 and the test method B.3 of the Council regulation No. 440/2008.

No mortality occurred during the study. No systemic clinical signs related to the administration of the test item were observed. The macroscopic examination of the animals at the end of the study did not reveal treatment-related changes.

In conclusion, the dermal LD50 of the test item 400112 was higher than 2000 mg/kg body weight in the rat.